Pilot Study of Umbilical Cord Blood Transplantation in Adult Patients With Advanced Hematopoietic Malignancies

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Antithymocyte globulin; Busulfan; Etoposide; Fludarabine; Prednisone; Tacrolimus
Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Cord blood stem cell transplant rejection; Graft-versus-host disease; Haematological malignancies; Hodgkin's disease; Lymphoma; Mantle-cell lymphoma; Multiple myeloma; Myelodysplastic syndromes; Peripheral T-cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
Focus Adverse reactions; Therapeutic Use

14 Aug 2013 Biomarkers information updated
03 Oct 2012 Status changed from discontinued to completed as reported by ClinicalTrials.gov. (NCT00304018)
03 Oct 2012 Status changed from discontinued to completed as reported by ClinicalTrials.gov. (NCT00304018)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com